Health & Medicinearticle2026-09-16

Widespread Loss of Heterozygosity and Endoreduplication in Odontogenic Myxoma

0 citations

Abstract

Odontogenic myxoma (OM) is an uncommon, locally aggressive odontogenic neoplasm with characteristic histologic and clinico-radiographic features but with potential for histologic overlap with other odontogenic and non-odontogenic entities and a non-specific immunoprofile. Widespread loss of heterozygosity (LOH) has been recently described in rare cases of OM. The aim of this study was to determine whether widespread LOH represents a recurrent molecular signature that can be leveraged for clinical decision-making. Allele-specific copy number variation data from chromosomal microarray were generated from 7 OM, comprising a combined prospective and retrospective cohort. Four tumors arose in the mandible and 3 in the maxilla in patients ranging in age from 18 to 94 years (median: 44), with tumor size ranging from 2.2 to 13.0 cm. Variable amounts of fibrous stroma (odontogenic "fibromyxoma") were present in 4/7 OM, and hypercellularity not typically appreciated in conventional OM was present in 3/7 cases. All OM (7/7) demonstrated widespread LOH, with 5 cases showing a near-haploid/low hypodiploid genomes (multiple monosomies) and 2 cases showing evidence of pseudo-hyperdiploidy due to probable endoreduplication. Both pseudo-hyperdiploid cases were ≥10 cm in size; 1 represented local recurrence. Chromosomes 1 to 3, 6, 9, 11, 13, 15, and 22 demonstrated LOH in ≥75% of cases (chromosomes 1 to 3, 6, and 9 in 100% of cases), while chromosomes 5, 12, 19, and 20 universally retained heterozygosity. Altogether, widespread LOH is a recurrent event in OM and a novel finding in odontogenic pathology, and allele-specific copy number variation analysis can serve as a diagnostic adjunct in challenging cases.

// Source

View paper (DOI)OpenAlexThe American Journal of Surgical PathologyPublished 2026-09-16

Authors: Ivan J. Stojanov, Melad N. Dababneh, Vincent Cracolici, Sana Qureshi, Travis Hattery, Mark Chen, Benjamin F. Smith, Diane O’Neill, DO Matthew Wolbert, Keith M. Schneider, Sheila Shurtleff, Caroline Astbury, Katherine B. Geiersbach, Sook-Bin Woo, Karen Fritchie, Grace E. Weber, J. Dermawan

Institutions: Harvard University, University at Buffalo, State University of New York, University of Alabama at Birmingham, Case Western Reserve University, Mayo Clinic in Arizona, Stratasys (Israel), Cleveland Clinic, Institute of Infection and Immunity, Mentor